As of today (2024-04-26), the Trailing Annual Dividend Yield of Taysha Gene Therapies is 0.00%.
The historical rank and industry rank for Taysha Gene Therapies's Dividend Yield % or its related term are showing as below:
TSHA's Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.59 * Ranked among companies with meaningful Dividend Yield % only.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Taysha Gene Therapies Dividend Yield % Historical Data
The historical data trend for Taysha Gene Therapies's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Taysha Gene Therapies's Dividend Yield %
For the Biotechnology subindustry, Taysha Gene Therapies's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Taysha Gene Therapies's Dividend Yield % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Taysha Gene Therapies's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Taysha Gene Therapies's Dividend Yield % falls into.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Taysha Gene Therapies Dividend Yield % Related Terms
Thank you for viewing the detailed overview of Taysha Gene Therapies's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.
Taysha Gene Therapies (Taysha Gene Therapies) Business Description
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. It is advancing a deep and sustainable product portfolio of 18 gene therapy product candidates, with exclusive options to acquire four additional development programs. Its product candidates include TSHA-101, TSHA-118, TSHA-102, TSHA-103, and TSHA-104.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSHA has been successfully added to your 